Direkt zum Inhalt
Merck

Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.

Bioorganic & medicinal chemistry letters (2013-02-14)
Rui Wang, Hong-Fan Shi, Jing-Feng Zhao, Yan-Ping He, Hong-Bin Zhang, Jian-Ping Liu
ZUSAMMENFASSUNG

A series of novel indole-imidazole derivatives have been prepared and evaluated in vitro on the aromatase inhibitory activities. The results suggested that proton or a small electron-withdrawing group at para-position of the phenyl ring would enhance the inhibitory activities and any bulky group should be avoided in order to keep a relative small volume for this kind of molecules.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Imidazol, ReagentPlus®, 99%
Sigma-Aldrich
Imidazol, ACS reagent, ≥99% (titration)
Sigma-Aldrich
Imidazol, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
Imidazol, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Imidazol-Pufferlösung, BioUltra, 1 M in H2O
Sigma-Aldrich
Imidazol, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Indol, ≥99%
Sigma-Aldrich
Imidazol -hydrochlorid
Sigma-Aldrich
Imidazol, ≥99% (titration), crystalline
Sigma-Aldrich
Imidazol, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Indol, ≥99%, FG
Supelco
Imidazol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Imidazolylnatrium, technical grade
Sigma-Aldrich
Imidazol, ReagentPlus®, 99%, Redi-Dri, free-flowing
Imidazol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Imidazol, Molecular Biology, ≥99% (titration), free-flowing, Redi-Dri